Please visit the Charlotte AHEC website to register and see a full listing of all their upcoming courses.
Date: Oct 17, 2017 12:00 PM - 02:00 PM
Participants have 60 days from the start of their program to claim CE credit and verify it has been upload to CPE Monitor. If your program requires the completion of a post test/eval/survey those items MUST be done before that 60 day window closes to receive credit for that program. Statements of credit can be viewed and printed from CPE Monitor. Statements of credit will no longer be printed and mailed to the participant. **No partial individual session credit will be given**
REGISTRATION NOTE: During the registration process, if a fee is required, please enter the zip code associated with your credit card's BILLING ADDRESS. For security purposes payments are processed through a separate system, so when prompted, please click “ok” to be taken to that site and complete your registration. Upon successful registration of this program you will receive an email confirmation/receipt and will be returned to this program page. When you are retuned to this page you will see a note at the top of the page reading “You are registered for this program.”
If you are not automatically returned to this page or see only a blank white screen your transaction was not successful, and you will need to try again.
If paying by check please mail to the address below:
301 Pharmacy Lane, CB# 7574 Beard Hall
Chapel Hill, NC 27599
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This knowledge-based CPE activity will review selected new drugs released over past 12 months using a “formulary approach.” Each medication’s characteristics such as pharmacology, pharmacokinetics, efficacy, safety, dosing, and cost will be compared to current medications, if any, used for similar indications. The audience will use criteria to determine if the new medication meets the criteria for addition to a health system formulary. The criteria include: is it a new pharmacologic class; is it more efficacious than current treatments; is it safer than current treatments; are there any clinically relevant pharmacokinetic advantages; or is the new medication more cost effective. In addition, new drugs of interest anticipated to be released over the next two years will be briefly discussed.
- Compare and contrast newly approved drugs with older agents regarding their pharmacology, pharmacokinetics, efficacy, safety, dosage and cost.
- Discuss the “formulary approach” to evaluating new drugs
- Describe potential utility of drugs in the pipeline for possible release in the next two years
Time: 12:00 PM - 02:00 PM